The farmaceutical group GSK has recently unveiled promising outcomes from its phase AReSVi-006 trial (Adult Respiratory Syncytial Virus). The study, which assessed the efficacy...
A study conducted by researchers at Harvard Medical School and published in the medical journal JAMA revealed that immunity from the Mpox vaccine would...